Beam Therapeutics Inc.
Beam Therapeutics Inc. (BEAM) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · BEAM · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
25
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Beam Therapeutics Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
BEAM insider buying and selling by quarter
BEAM insider selling · BEAM insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · BEAM ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
BEAM executive sell shares · BEAM board member insider trading · BEAM insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Apr 1, 2026 | Evans John M. CEO · Director | Sale | 30,078 | $739K | Form 4 |
| Apr 1, 2026 | Simon Amy Chief Medical Officer | Sale | 6,700 | $165K | Form 4 |
| Apr 1, 2026 | Cavanagh Bethany J SVP, Finance and Treasurer | Sale | 3,242 | $80K | Form 4 |
| Apr 1, 2026 | Bellon Christine Chief Legal Officer | Sale | 5,956 | $146K | Form 4 |
| Apr 1, 2026 | Ciaramella Giuseppe President | Sale | 11,810 | $290K | Form 4 |
| Mar 31, 2026 | Bellon Christine Chief Legal Officer | Award | 20,000 | — | Form 4 |
| Mar 31, 2026 | Cavanagh Bethany J SVP, Finance and Treasurer | Award | 20,000 | — | Form 4 |
| Mar 31, 2026 | Simon Amy Chief Medical Officer | Award | 31,750 | — | Form 4 |
| Mar 31, 2026 | Emany Sravan Kumar CFO | Award | 31,750 | — | Form 4 |
| Mar 31, 2026 | Ciaramella Giuseppe President | Award | 40,000 | — | Form 4 |
| Mar 31, 2026 | Evans John M. CEO · Director | Award | 90,000 | — | Form 4 |
| Mar 31, 2026 | Evans John M. CEO · Director | Option | 25,000 | $17K | Form 4 |
| Mar 31, 2026 | Evans John M. CEO · Director | Sale | 25,000 | $569K | Form 4 |
| Mar 30, 2026 | Evans John M. CEO · Director | Sale | 25,000 | $559K | Form 4 |
| Feb 24, 2026 | Ciaramella Giuseppe President | Option | 35,000 | $595K | Form 4 |
| Feb 24, 2026 | Ciaramella Giuseppe President | Sale | 35,000 | $1.12M⚡ | Form 4 |
| Jan 30, 2026 | Evans John M. CEO · Director | Option | 25,000 | $17K | Form 4 |
| Jan 29, 2026 | Evans John M. CEO · Director | Option | 19,336 | $13K | Form 4 |
| Jan 29, 2026 | Evans John M. CEO · Director | Sale | 16,333 | $477K | Form 4 |
| Jan 30, 2026 | Evans John M. CEO · Director | Sale | 22,094 | $625K | Form 4 |
| Jan 30, 2026 | Evans John M. CEO · Director | Sale | 2,906 | $84K | Form 4 |
| Jan 29, 2026 | Evans John M. CEO · Director | Sale | 8,667 | $258K | Form 4 |
| Jan 22, 2026 | Cavanagh Bethany J SVP, Finance and Treasurer | Sale | 6,198 | $217K | Form 4 |
| Jan 22, 2026 | Bellon Christine Chief Legal Officer | Sale | 1,371 | $47K | Form 4 |
| Jan 20, 2026 | Cavanagh Bethany J SVP, Finance and Treasurer | Sale | 3,034 | $91K | Form 4 |
Cavanagh Bethany J
SVP, Finance and Treasurer
Date
Apr 1
Shares
3,242
Price
$24.58
Value
$80K
Bellon Christine
Chief Legal Officer
Date
Apr 1
Shares
5,956
Price
$24.58
Value
$146K
Cavanagh Bethany J
SVP, Finance and Treasurer
Date
Mar 31
Shares
20,000
Price
—
Value
—
Ciaramella Giuseppe
President
Date
Feb 24
Shares
35,000
Price
$32.00
Value
$1.12M ⚡
Cavanagh Bethany J
SVP, Finance and Treasurer
Date
Jan 22
Shares
6,198
Price
$35.00
Value
$217K
Bellon Christine
Chief Legal Officer
Date
Jan 22
Shares
1,371
Price
$34.00
Value
$47K
Cavanagh Bethany J
SVP, Finance and Treasurer
Date
Jan 20
Shares
3,034
Price
$30.12
Value
$91K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About BEAM insider trading
BEAM insider trades
Beam Therapeutics Inc. (BEAM) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Evans John M. (CEO · Director), Bellon Christine (Chief Legal Officer), Simon Amy (Chief Medical Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. BEAM insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Beam Therapeutics Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
BEAM insider trading · 5 questionsThe insiders of Beam Therapeutics Inc. (BEAM) include executives and directors such as Evans John M. (CEO · Director), Bellon Christine (Chief Legal Officer), Simon Amy (Chief Medical Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026